Related Experiment Video
Updated: Dec 9, 2025
10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.7K
Myasthenia gravis and pregnancy
Kavita M Grover1,2, Naganand Sripathi1,3
1Department of Neurology, Henry Ford Hospital, Detroit, Michigan.
Muscle & Nerve
|September 15, 2020
Summary
Myasthenia gravis (MG) is an autoimmune disorder diagnosed in women of reproductive age and older men. Careful management and multidisciplinary monitoring are crucial for pregnant individuals with MG and their newborns.
Area of Science:
- Neurology
- Immunology
- Maternal-Fetal Medicine
Background:
- Myasthenia gravis (MG) is an autoimmune disorder with a bimodal age distribution.
- MG can be diagnosed during pregnancy, necessitating specialized care.
- Management involves symptomatic treatment and immunosuppression.
Purpose of the Study:
- To discuss the management of myasthenia gravis in women of reproductive age.
- To highlight the importance of medication choice and risk assessment for pregnancy.
- To emphasize peripartum and neonatal monitoring strategies.
Main Methods:
- Review of current management strategies for MG in pregnancy.
- Discussion of medication risks and benefits.
- Emphasis on multidisciplinary care coordination.
Main Results:
- Treatment decisions for MG in pregnant women require careful consideration of risks and benefits.
- Peripartum period necessitates close monitoring of maternal and fetal well-being.
- Neonatal monitoring is essential and requires a coordinated team approach.
Conclusions:
- Optimal management of myasthenia gravis during pregnancy involves informed medication choices and vigilant monitoring.
- A multidisciplinary team approach is vital for ensuring the best outcomes for both mother and child.
- Understanding the complexities of MG in pregnancy is critical for healthcare providers.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
2.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.5K
01:15Myasthenia Gravis: Diagnostic Tests
1.7K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.7K
01:28Disorders of the Skeletal Muscle
1.5K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.5K
01:26Chemical Synapses
10.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.8K
01:26Chemical Synapses
4.0K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.0K
01:10Muscle Contraction
8.5K
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive...
8.5K